Citadel Advisors’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.57M | Sell |
703,644
-635,374
| -47% | -$4.13M | ﹤0.01% | 2008 |
|
|
2025
Q1 | $10.6M | Buy |
1,339,018
+727,705
| +119% | +$5.77M | ﹤0.01% | 1217 |
|
|
2024
Q4 | $7.75M | Buy |
611,313
+127,052
| +26% | +$1.61M | ﹤0.01% | 1474 |
|
|
2024
Q3 | $6.75M | Buy |
484,261
+114,653
| +31% | +$1.6M | ﹤0.01% | 1532 |
|
|
2024
Q2 | $5.09M | Buy |
369,608
+322,343
| +682% | +$4.44M | ﹤0.01% | 1677 |
|
|
2024
Q1 | $781K | Buy |
47,265
+39,998
| +550% | +$661K | ﹤0.01% | 3449 |
|
|
2023
Q4 | $106K | Buy |
7,267
+513
| +8% | +$7.49K | ﹤0.01% | 4854 |
|
|
2023
Q3 | $82.9K | Sell |
6,754
-765,402
| -99% | -$9.39M | ﹤0.01% | 4907 |
|
|
2023
Q2 | $9.22M | Buy |
772,156
+378,072
| +96% | +$4.51M | ﹤0.01% | 1263 |
|
|
2023
Q1 | $5.27M | Buy |
394,084
+387,213
| +5,635% | +$5.18M | ﹤0.01% | 1770 |
|
|
2022
Q4 | $148K | Sell |
6,871
-41,077
| -86% | -$884K | ﹤0.01% | 4842 |
|
|
2022
Q3 | $961K | Sell |
47,948
-11,856
| -20% | -$238K | ﹤0.01% | 3453 |
|
|
2022
Q2 | $1.07M | Sell |
59,804
-51,932
| -46% | -$929K | ﹤0.01% | 3334 |
|
|
2022
Q1 | $1.11M | Buy |
+111,736
| New | +$1.11M | ﹤0.01% | 3630 |
|